Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Immune Response to SARS-CoV-2 Vaccination in Patients With Systemic Lupus

NCT04894253 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT04894253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04894253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Immune Response to SARS-CoV-2 Vaccination in Patients With Systemic Lupus
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Terminated
Start date
June 7, 2021
Completion date
December 22, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus